Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Rajkumar Boddu, Sivacharan Kollipara, Gautam Vijaywargi & Tausif Ahmed. (2023) Power of integrating PBPK with PBBM (PBPK-BM): a single model predicting food effect, gender impact, drug-drug interactions and bioequivalence in fasting & fed conditions. Xenobiotica 53:4, pages 260-278.
Read now
Read now
Mariana Mauro, Jose Salvador Lepera, Bruno Borsari, Jorge Manuel Vieira Capela & Natália Valadares de Moraes. (2018) Effect of inhalation exposure to toluene on the activity of organic anion transporting polypeptide (Oatp) using pravastatin as a probe drug in rats. Xenobiotica 48:7, pages 734-738.
Read now
Read now
Guangyi Yang, Shufan Ge, Rashim Singh, Sumit Basu, Katherine Shatzer, Ming Zen, Jiong Liu, Yifan Tu, Chenning Zhang, Jinbao Wei, Jian Shi, Lijun Zhu, Zhongqiu Liu, Yuan Wang, Song Gao & Ming Hu. (2017) Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metabolism Reviews 49:2, pages 105-138.
Read now
Read now
Aleksi Tornio, Pertti J. Neuvonen, Mikko Niemi & Janne T. Backman. (2017) Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 83-95.
Read now
Read now
Eva Ramboer, Tamara Vanhaecke, Vera Rogiers & Mathieu Vinken. (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metabolism Reviews 45:2, pages 196-217.
Read now
Read now
Fabian Müller & Martin F Fromm. (2011) Transporter-Mediated Drug–Drug Interactions. Pharmacogenomics 12:7, pages 1017-1037.
Read now
Read now
Alice C Rodrigues. (2010) Efflux and uptake transporters as determinants of statin response. Expert Opinion on Drug Metabolism & Toxicology 6:5, pages 621-632.
Read now
Read now
A. Ayrton & P. Morgan. (2008) Role of transport proteins in drug discovery and development: a pharmaceutical perspective. Xenobiotica 38:7-8, pages 676-708.
Read now
Read now
Articles from other publishers (43)
Eleni Papantoniou, Konstantinos Arvanitakis, Konstantinos Markakis, Stavros P. Papadakos, Olga Tsachouridou, Djordje S. Popovic, Georgios Germanidis, Theocharis Koufakis & Kalliopi Kotsa. (2024) Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas. Life 14:4, pages 449.
Crossref
Crossref
Yi‐An Bi, Samantha Jordan, Amanda King‐Ahmad, Mark A. West & Manthena V. S. Varma. (2024)
Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of
OATP1B‐CYP2C8
Interplay
. Clinical Pharmacology & Therapeutics.
Crossref
Crossref
Islam Younis, Elijah Weber, Cara Nelson, Brian J. Kirby, Gong Shen, Deqing Xiao, Timothy R. Watkins & Ahmed A. Othman. (2023) Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist. Clinical Pharmacokinetics 62:4, pages 609-621.
Crossref
Crossref
Samantha Medwid, Richard H. Ho & Richard B. Kim. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Manish B. Shah. (2022) Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges. Biomolecules 12:9, pages 1218.
Crossref
Crossref
Joshua Zechner, Susan M. Britza, Rachael Farrington, Roger W. Byard & Ian F. Musgrave. (2022) Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis. Life Sciences 291, pages 119975.
Crossref
Crossref
Erkka Järvinen, Feng Deng, Wilma Kiander, Alli Sinokki, Heidi Kidron & Noora Sjöstedt. (2022) The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates. Frontiers in Pharmacology 12.
Crossref
Crossref
Nina Hanke, José David Gómez-Mantilla, Naoki Ishiguro, Peter Stopfer & Valerie Nock. (2021) Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions. Pharmaceutical Research 38:10, pages 1645-1661.
Crossref
Crossref
Feng Deng, Suvi-Kukka Tuomi, Mikko Neuvonen, Päivi Hirvensalo, Sami Kulju, Christoph Wenzel, Stefan Oswald, Anne M. Filppula & Mikko Niemi. (2021) Comparative Hepatic and Intestinal Efflux Transport of Statins. Drug Metabolism and Disposition 49:9, pages 750-759.
Crossref
Crossref
Xiaodong Liu. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
241
291
.
Merle Myerson. 2019. Cardiovascular Care in Patients With HIV. Cardiovascular Care in Patients With HIV
23
45
.
Khondoker Alam, Alexandra Crowe, Xueying Wang, Pengyue Zhang, Kai Ding, Lang Li & Wei Yue. (2018) Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. International Journal of Molecular Sciences 19:3, pages 855.
Crossref
Crossref
Chunsheng He, Amber Griffies, Xuan Liu, Robert Adamczyk & Shu-Pang Huang. (2018) A Pooled Analysis of Pharmacokinetic Variability Information for Common Probe Substrates Used in Drug-Drug Interaction Studies. Pharmacology 101:3-4, pages 170-175.
Crossref
Crossref
R.H. Ho & R.B. Kim. 2018. Comprehensive Toxicology. Comprehensive Toxicology
574
616
.
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
387
430
.
Q Wang, M Zheng & T Leil. (2017) Investigating Transporter-Mediated Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin. CPT: Pharmacometrics & Systems Pharmacology 6:4, pages 228-238.
Crossref
Crossref
MV Varma, E Kimoto, R Scialis, Y Bi, J Lin, H Eng, AS Kalgutkar, AF El‐Kattan, AD Rodrigues & LM Tremaine. (2016) Transporter‐Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug–Drug Interactions of Montelukast. Clinical Pharmacology & Therapeutics 101:3, pages 406-415.
Crossref
Crossref
A Emami Riedmaier, O Burk, B A C van Eijck, E Schaeffeler, K Klein, S Fehr, S Biskup, S Müller, S Winter, U M Zanger, M Schwab & A T Nies. (2015) Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors. The Pharmacogenomics Journal 16:4, pages 341-351.
Crossref
Crossref
Xiaolin Sun, Junxiu Li, Chaorui Guo, Han Xing, Jie Xu, Yanli Wen, Zhixia Qiu, Qiuyang Zhang, Yi Zheng, Xijing Chen & Di Zhao. (2016) Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s. Drug Metabolism and Pharmacokinetics 31:4, pages 269-275.
Crossref
Crossref
Merle Myerson. (2016) Lipid Management in Human Immunodeficiency Virus. Endocrinology and Metabolism Clinics of North America 45:1, pages 141-169.
Crossref
Crossref
Emi Kimoto, Rui Li, Renato J. Scialis, Yurong Lai & Manthena V. S. Varma. (2015)
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-
O
-β-Glucuronide
. Molecular Pharmaceutics 12:11, pages 3943-3952.
Crossref
Crossref
Merle Myerson, Carlos Malvestutto & Judith A. Aberg. (2015) Management of lipid disorders in patients living with HIV. The Journal of Clinical Pharmacology 55:9, pages 957-974.
Crossref
Crossref
Manthena V. S. Varma, Jian Lin, Yi-an Bi, Emi Kimoto & A. David Rodrigues. (2015)
Quantitative Rationalization of Gemfibrozil Drug Interactions: Consideration of Transporters-Enzyme Interplay and the Role of Circulating Metabolite Gemfibrozil 1-
O
-
β
-Glucuronide
. Drug Metabolism and Disposition 43:7, pages 1108-1118.
Crossref
Crossref
Merle Myerson. (2015) Lipid Management in Human Immunodeficiency Virus. Cardiology Clinics 33:2, pages 277-298.
Crossref
Crossref
Tomohisa Nakada, Tomoko Kito, Katsuhisa Inoue, Satohiro Masuda, Ken-ichi Inui, Kazuo Matsubara, Yoshinori Moriyama, Noriko Hisanaga, Yasuhisa Adachi, Masayuki Suzuki, Ichimaro Yamada & Hiroyuki Kusuhara. (2014) Evaluation of the Potency of Telaprevir and Its Metabolites as Inhibitors of Renal Organic Cation Transporters, a Potential Mechanism for the Elevation of Serum Creatinine. Drug Metabolism and Pharmacokinetics 29:3, pages 266-271.
Crossref
Crossref
A M Filppula, A Tornio, M Niemi, P J Neuvonen & J T Backman. (2013) Gemfibrozil Impairs Imatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite. Clinical Pharmacology & Therapeutics 94:3, pages 383-393.
Crossref
Crossref
Manthena V. S. Varma, Yurong Lai, Emi Kimoto, Theunis C. Goosen, Ayman F. El-Kattan & Vikas Kumar. (2013) Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide. Pharmaceutical Research 30:4, pages 1188-1199.
Crossref
Crossref
Toshiyuki Kudo, Akihiro Hisaka, Yuichi Sugiyama & Kiyomi Ito. (2013) Analysis of the Repaglinide Concentration Increase Produced by Gemfibrozil and Itraconazole Based on the Inhibition of the Hepatic Uptake Transporter and Metabolic Enzymes. Drug Metabolism and Disposition 41:2, pages 362-371.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
353
454
.
Maria Ulvestad, Malin Darnell, Espen Molden, Ewa Ellis, Anders Åsberg & Tommy B. Andersson. (2012) Evaluation of Organic Anion-Transporting Polypeptide 1B1 and CYP3A4 Activities in Primary Human Hepatocytes and HepaRG Cells Cultured in a Dynamic Three-Dimensional Bioreactor System. Journal of Pharmacology and Experimental Therapeutics 343:1, pages 145-156.
Crossref
Crossref
Manthena V. S. Varma, Yurong Lai, Bo Feng, John Litchfield, Theunis C. Goosen & Arthur Bergman. (2012) Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions. Pharmaceutical Research 29:10, pages 2860-2873.
Crossref
Crossref
Pradeep Sharma, Caroline J. Butters, Veronica Smith, Robert Elsby & Dominic Surry. (2012) Prediction of the in vivo OATP1B1-mediated drug–drug interaction potential of an investigational drug against a range of statins. European Journal of Pharmaceutical Sciences 47:1, pages 244-255.
Crossref
Crossref
A. García-Sabina, J. Gulín-Dávila, P. Sempere-Serrano, C. González-Juanatey & R. Martínez-Pacheco. (2012) Consideraciones específicas en la prescripción e intercambio terapéutico de estatinas. Farmacia Hospitalaria 36:2, pages 97-108.
Crossref
Crossref
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
273
298
.
Maria Ulvestad, Petter Björquist, Espen Molden, Anders Åsberg & Tommy B. Andersson. (2011) OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. Biochemical Pharmacology 82:9, pages 1219-1226.
Crossref
Crossref
Aiming Liu, Julin Yang, Frank J. Gonzalez, Gary Q. Cheng & Renke Dai. (2010) Biphasic Regulation of Intracellular Calcium by Gemfibrozil Contributes to Inhibiting L6 Myoblast Differentiation: Implications for Clinical Myotoxicity. Chemical Research in Toxicology 24:2, pages 229-237.
Crossref
Crossref
Yoshihisa Shitara. (2011) Clinical Importance of OATP1B1 and OATP1B3 in DrugDrug Interactions. Drug Metabolism and Pharmacokinetics 26:3, pages 220-227.
Crossref
Crossref
Joseph E. Rower, Lane R. Bushman, Kyle P. Hammond, Rajendra S. Kadam & Christina L. Aquilante. (2010) Validation of an LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic study. Biomedical Chromatography 24:12, pages 1300-1308.
Crossref
Crossref
Ebba Bergman, Elin M. Matsson, Mikael Hedeland, Ulf Bondesson, Lars Knutson & Hans Lennernäs. (2013) Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers. The Journal of Clinical Pharmacology 50:9, pages 1039-1049.
Crossref
Crossref
Henriette E. Meyer zu Schwabedissen & Richard B. Kim. (2009) Hepatic OATP1B Transporters and Nuclear Receptors PXR and CAR: Interplay, Regulation of Drug Disposition Genes, and Single Nucleotide Polymorphisms. Molecular Pharmaceutics 6:6, pages 1644-1661.
Crossref
Crossref
Kristin H Busse, Colleen Hadigan, Cheryl Chairez, Raul M Alfaro, Elizabeth Formentini, Joseph A Kovacs & Scott R Penzak. (2009) Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes 52:2, pages 235-239.
Crossref
Crossref
Terry A. Jacobson. (2009) Myopathy with statin–fibrate combination therapy: clinical considerations. Nature Reviews Endocrinology 5:9, pages 507-518.
Crossref
Crossref
Christopher Rowan, Allen D. Brinker, Parivash Nourjah, Jennie Chang, Andrew Mosholder, Jeffrey S. Barrett & Mark Avigan. (2009) Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors. Pharmacoepidemiology and Drug Safety 18:4, pages 301-309.
Crossref
Crossref